TY - JOUR
T1 - Feasibility of brain intra-axonal microstructure imaging with ultrahigh B-encoding using MAGNUS ultra-high-performance gradients
AU - Abad, Nastaren
AU - Bhushan, Chitresh
AU - Ajala, Afis
AU - Sprenger, Tim
AU - Marinelli, Luca
AU - Morris, H. Douglas
AU - DeMarco, J. Kevin
AU - Hood, Maureen
AU - Kohls, Gail
AU - Ho, Vincent B.
AU - Foo, Thomas K.F.
N1 - Publisher Copyright:
© 2025 The Authors. Published under a Creative Commons Attribution 4.0 International (CC BY 4.0) license.
PY - 2025/7/17
Y1 - 2025/7/17
N2 - The MAGNUS high-performance MRI gradient platform delivers Gmax = 200–300 mT/m, and SRmax = 500–750 T/m/s using standard clinical 3.0T system power electronics. This enables the exploration of an expanded diffusion parameter space (b~7–≥30 ms/μm2) with reasonable SNR, along with substantially shorter diffusion encoding pulse-widths, echo times, reduced distortion, and blurring from shorter echo spacing. The choice of high b-value diffusion-encoding space can effectively suppress contributions from extra-axonal water, allowing for simplified biophysical models to be explored for non-invasive mapping of intra-axonal content. In this study, the feasibility and reproducibility of mapping in-vivo whole-brain effective intra-axonal radius (reff), using MAGNUS was assessed. By making use of a test-retest paradigm, reproducibility and sensitivity were evaluated for this new biomarker. Six healthy volunteers were imaged, after obtaining written informed consent, under local IRB-approved protocols with a focus on utilizing the maximum gradient strength of 300 mT/m. Multi-shell dMRI protocols, with a lower bound b = 7 ms/μm2 were used for feasibility analysis and short (same-day) and long-term (7-days) test-retest repeatability. To aid in increased precision, a framework for rigorous post-processing incorporating real-valued diffusion data handling and gradient non-linearity correction was integrated. At 300 mT/m, simulations highlight a lower bound threshold for robust detectability of reff >1.41 μm. The simulated distribution function was consistent with in-vivo measurements, where a mean reff = 2.75 ± 0.15 μm was observed for whole-brain white matter (WM) across all volunteers. Left-Right brain white matter asymmetry as a function of reff was noted with segmentations of well-reported parcels, such as the corpus callosum and corticospinal tract, demonstrating good agreement with prior literature. Data highlighted good repeatability in voxel-wise and parcel-based estimates for short- and long-term test-retest analysis. A mean coefficient of variance of 3.2% for WM parcels across all volunteers was noted, with a reproducibility coefficient of 0.16 μm (6.6%) highlighting a lack of systemic bias. This study reports on the feasibility of investigating reff using MAGNUS. The analysis of repeatability established the floor of changes in the brain that can be observed in studies leveraging reff as a neuroimaging biomarker for white matter integrity or for investigating neuroplastic processes in the brain.
AB - The MAGNUS high-performance MRI gradient platform delivers Gmax = 200–300 mT/m, and SRmax = 500–750 T/m/s using standard clinical 3.0T system power electronics. This enables the exploration of an expanded diffusion parameter space (b~7–≥30 ms/μm2) with reasonable SNR, along with substantially shorter diffusion encoding pulse-widths, echo times, reduced distortion, and blurring from shorter echo spacing. The choice of high b-value diffusion-encoding space can effectively suppress contributions from extra-axonal water, allowing for simplified biophysical models to be explored for non-invasive mapping of intra-axonal content. In this study, the feasibility and reproducibility of mapping in-vivo whole-brain effective intra-axonal radius (reff), using MAGNUS was assessed. By making use of a test-retest paradigm, reproducibility and sensitivity were evaluated for this new biomarker. Six healthy volunteers were imaged, after obtaining written informed consent, under local IRB-approved protocols with a focus on utilizing the maximum gradient strength of 300 mT/m. Multi-shell dMRI protocols, with a lower bound b = 7 ms/μm2 were used for feasibility analysis and short (same-day) and long-term (7-days) test-retest repeatability. To aid in increased precision, a framework for rigorous post-processing incorporating real-valued diffusion data handling and gradient non-linearity correction was integrated. At 300 mT/m, simulations highlight a lower bound threshold for robust detectability of reff >1.41 μm. The simulated distribution function was consistent with in-vivo measurements, where a mean reff = 2.75 ± 0.15 μm was observed for whole-brain white matter (WM) across all volunteers. Left-Right brain white matter asymmetry as a function of reff was noted with segmentations of well-reported parcels, such as the corpus callosum and corticospinal tract, demonstrating good agreement with prior literature. Data highlighted good repeatability in voxel-wise and parcel-based estimates for short- and long-term test-retest analysis. A mean coefficient of variance of 3.2% for WM parcels across all volunteers was noted, with a reproducibility coefficient of 0.16 μm (6.6%) highlighting a lack of systemic bias. This study reports on the feasibility of investigating reff using MAGNUS. The analysis of repeatability established the floor of changes in the brain that can be observed in studies leveraging reff as a neuroimaging biomarker for white matter integrity or for investigating neuroplastic processes in the brain.
KW - axonal integrity
KW - brain microstructure
KW - effective intra-axonal radius
KW - high performance gradients
KW - magnetic resonance imaging
KW - neuroimaging biomarkers
KW - ultra-high diffusion encoding
UR - http://www.scopus.com/inward/record.url?scp=105011532258&partnerID=8YFLogxK
U2 - 10.1162/IMAG.a.68
DO - 10.1162/IMAG.a.68
M3 - Article
AN - SCOPUS:105011532258
SN - 2837-6056
VL - 3
JO - Imaging Neuroscience
JF - Imaging Neuroscience
M1 - IMAG.a.68
ER -